<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1997-11-01" modified="2017-05-10" version="185">
<accession>Q13546</accession>
<accession>A0AV89</accession>
<accession>B2RAG1</accession>
<accession>B4E3F9</accession>
<accession>Q13180</accession>
<accession>Q59H33</accession>
<name>RIPK1_HUMAN</name>
<protein>
<recommendedName>
<fullName>Receptor-interacting serine/threonine-protein kinase 1</fullName>
<ecNumber>2.7.11.1</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Cell death protein RIP</fullName>
</alternativeName>
<alternativeName>
<fullName>Receptor-interacting protein 1</fullName>
<shortName>RIP-1</shortName>
</alternativeName>
<alternativeName>
<fullName>Serine/threonine-protein kinase RIP</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">RIPK1</name>
<name type="synonym">RIP</name>
<name type="synonym">RIP1</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1996" name="Immunity" volume="4" first="387" last="396">
<title>TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex.</title>
<authorList>
<person name="Hsu H."/>
<person name="Huang J."/>
<person name="Shu H.-B."/>
<person name="Baichwal V.R."/>
<person name="Goeddel D.V."/>
</authorList>
<dbReference type="PubMed" id="8612133"/>
<dbReference type="DOI" id="10.1016/S1074-7613(00)80252-6"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>AUTOPHOSPHORYLATION</scope>
<scope>MUTAGENESIS OF LYS-45</scope>
<scope>INTERACTION WITH TRADD; TRAF1; TRAF2 AND TRAF3</scope>
<scope>VARIANT VAL-438</scope>
<source>
<tissue>Umbilical vein endothelial cell</tissue>
</source>
</reference>
<reference key="2">
<citation type="submission" date="1998-08" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Huang J."/>
<person name="Hsu H."/>
<person name="Baichwal V.R."/>
<person name="Goeddel D.V."/>
</authorList>
</citation>
<scope>SEQUENCE REVISION TO 120</scope>
</reference>
<reference key="3">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 15-671 (ISOFORM 2)</scope>
<source>
<tissue>Adrenal gland</tissue>
<tissue>Uterus</tissue>
</source>
</reference>
<reference key="4">
<citation type="submission" date="2004-07" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="SeattleSNPs variation discovery resource"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANT LYS-234</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2003" name="Nature" volume="425" first="805" last="811">
<title>The DNA sequence and analysis of human chromosome 6.</title>
<authorList>
<person name="Mungall A.J."/>
<person name="Palmer S.A."/>
<person name="Sims S.K."/>
<person name="Edwards C.A."/>
<person name="Ashurst J.L."/>
<person name="Wilming L."/>
<person name="Jones M.C."/>
<person name="Horton R."/>
<person name="Hunt S.E."/>
<person name="Scott C.E."/>
<person name="Gilbert J.G.R."/>
<person name="Clamp M.E."/>
<person name="Bethel G."/>
<person name="Milne S."/>
<person name="Ainscough R."/>
<person name="Almeida J.P."/>
<person name="Ambrose K.D."/>
<person name="Andrews T.D."/>
<person name="Ashwell R.I.S."/>
<person name="Babbage A.K."/>
<person name="Bagguley C.L."/>
<person name="Bailey J."/>
<person name="Banerjee R."/>
<person name="Barker D.J."/>
<person name="Barlow K.F."/>
<person name="Bates K."/>
<person name="Beare D.M."/>
<person name="Beasley H."/>
<person name="Beasley O."/>
<person name="Bird C.P."/>
<person name="Blakey S.E."/>
<person name="Bray-Allen S."/>
<person name="Brook J."/>
<person name="Brown A.J."/>
<person name="Brown J.Y."/>
<person name="Burford D.C."/>
<person name="Burrill W."/>
<person name="Burton J."/>
<person name="Carder C."/>
<person name="Carter N.P."/>
<person name="Chapman J.C."/>
<person name="Clark S.Y."/>
<person name="Clark G."/>
<person name="Clee C.M."/>
<person name="Clegg S."/>
<person name="Cobley V."/>
<person name="Collier R.E."/>
<person name="Collins J.E."/>
<person name="Colman L.K."/>
<person name="Corby N.R."/>
<person name="Coville G.J."/>
<person name="Culley K.M."/>
<person name="Dhami P."/>
<person name="Davies J."/>
<person name="Dunn M."/>
<person name="Earthrowl M.E."/>
<person name="Ellington A.E."/>
<person name="Evans K.A."/>
<person name="Faulkner L."/>
<person name="Francis M.D."/>
<person name="Frankish A."/>
<person name="Frankland J."/>
<person name="French L."/>
<person name="Garner P."/>
<person name="Garnett J."/>
<person name="Ghori M.J."/>
<person name="Gilby L.M."/>
<person name="Gillson C.J."/>
<person name="Glithero R.J."/>
<person name="Grafham D.V."/>
<person name="Grant M."/>
<person name="Gribble S."/>
<person name="Griffiths C."/>
<person name="Griffiths M.N.D."/>
<person name="Hall R."/>
<person name="Halls K.S."/>
<person name="Hammond S."/>
<person name="Harley J.L."/>
<person name="Hart E.A."/>
<person name="Heath P.D."/>
<person name="Heathcott R."/>
<person name="Holmes S.J."/>
<person name="Howden P.J."/>
<person name="Howe K.L."/>
<person name="Howell G.R."/>
<person name="Huckle E."/>
<person name="Humphray S.J."/>
<person name="Humphries M.D."/>
<person name="Hunt A.R."/>
<person name="Johnson C.M."/>
<person name="Joy A.A."/>
<person name="Kay M."/>
<person name="Keenan S.J."/>
<person name="Kimberley A.M."/>
<person name="King A."/>
<person name="Laird G.K."/>
<person name="Langford C."/>
<person name="Lawlor S."/>
<person name="Leongamornlert D.A."/>
<person name="Leversha M."/>
<person name="Lloyd C.R."/>
<person name="Lloyd D.M."/>
<person name="Loveland J.E."/>
<person name="Lovell J."/>
<person name="Martin S."/>
<person name="Mashreghi-Mohammadi M."/>
<person name="Maslen G.L."/>
<person name="Matthews L."/>
<person name="McCann O.T."/>
<person name="McLaren S.J."/>
<person name="McLay K."/>
<person name="McMurray A."/>
<person name="Moore M.J.F."/>
<person name="Mullikin J.C."/>
<person name="Niblett D."/>
<person name="Nickerson T."/>
<person name="Novik K.L."/>
<person name="Oliver K."/>
<person name="Overton-Larty E.K."/>
<person name="Parker A."/>
<person name="Patel R."/>
<person name="Pearce A.V."/>
<person name="Peck A.I."/>
<person name="Phillimore B.J.C.T."/>
<person name="Phillips S."/>
<person name="Plumb R.W."/>
<person name="Porter K.M."/>
<person name="Ramsey Y."/>
<person name="Ranby S.A."/>
<person name="Rice C.M."/>
<person name="Ross M.T."/>
<person name="Searle S.M."/>
<person name="Sehra H.K."/>
<person name="Sheridan E."/>
<person name="Skuce C.D."/>
<person name="Smith S."/>
<person name="Smith M."/>
<person name="Spraggon L."/>
<person name="Squares S.L."/>
<person name="Steward C.A."/>
<person name="Sycamore N."/>
<person name="Tamlyn-Hall G."/>
<person name="Tester J."/>
<person name="Theaker A.J."/>
<person name="Thomas D.W."/>
<person name="Thorpe A."/>
<person name="Tracey A."/>
<person name="Tromans A."/>
<person name="Tubby B."/>
<person name="Wall M."/>
<person name="Wallis J.M."/>
<person name="West A.P."/>
<person name="White S.S."/>
<person name="Whitehead S.L."/>
<person name="Whittaker H."/>
<person name="Wild A."/>
<person name="Willey D.J."/>
<person name="Wilmer T.E."/>
<person name="Wood J.M."/>
<person name="Wray P.W."/>
<person name="Wyatt J.C."/>
<person name="Young L."/>
<person name="Younger R.M."/>
<person name="Bentley D.R."/>
<person name="Coulson A."/>
<person name="Durbin R.M."/>
<person name="Hubbard T."/>
<person name="Sulston J.E."/>
<person name="Dunham I."/>
<person name="Rogers J."/>
<person name="Beck S."/>
</authorList>
<dbReference type="PubMed" id="14574404"/>
<dbReference type="DOI" id="10.1038/nature02055"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<scope>VARIANT VAL-438</scope>
</reference>
<reference key="7">
<citation type="submission" date="2005-03" db="EMBL/GenBank/DDBJ databases">
<title>Homo sapiens protein coding cDNA.</title>
<authorList>
<person name="Totoki Y."/>
<person name="Toyoda A."/>
<person name="Takeda T."/>
<person name="Sakaki Y."/>
<person name="Tanaka A."/>
<person name="Yokoyama S."/>
<person name="Ohara O."/>
<person name="Nagase T."/>
<person name="Kikuno R.F."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 153-671</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="1995" name="Cell" volume="81" first="513" last="523">
<title>RIP: a novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death.</title>
<authorList>
<person name="Stanger B.Z."/>
<person name="Leder P."/>
<person name="Lee T.-H."/>
<person name="Kim E."/>
<person name="Seed B."/>
</authorList>
<dbReference type="PubMed" id="7538908"/>
<dbReference type="DOI" id="10.1016/0092-8674(95)90072-1"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 300-671</scope>
<scope>VARIANT VAL-438</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="9">
<citation type="journal article" date="1999" name="Genes Dev." volume="13" first="2514" last="2526">
<title>Cleavage of the death domain kinase RIP by caspase-8 prompts TNF-induced apoptosis.</title>
<authorList>
<person name="Lin Y."/>
<person name="Devin A."/>
<person name="Rodriguez Y."/>
<person name="Liu Z.-G."/>
</authorList>
<dbReference type="PubMed" id="10521396"/>
<dbReference type="DOI" id="10.1101/gad.13.19.2514"/>
</citation>
<scope>CLEAVAGE BY CASPASE-8</scope>
<scope>MUTAGENESIS OF ASP-324</scope>
</reference>
<reference key="10">
<citation type="journal article" date="1999" name="EMBO J." volume="18" first="3044" last="3053">
<title>The interaction of p62 with RIP links the atypical PKCs to NF-kappaB activation.</title>
<authorList>
<person name="Sanz L."/>
<person name="Sanchez P."/>
<person name="Lallena M.-J."/>
<person name="Diaz-Meco M.T."/>
<person name="Moscat J."/>
</authorList>
<dbReference type="PubMed" id="10356400"/>
<dbReference type="DOI" id="10.1093/emboj/18.11.3044"/>
</citation>
<scope>INTERACTION WITH SQSTM1 AND TRAF2</scope>
<scope>DOMAIN</scope>
</reference>
<reference key="11">
<citation type="journal article" date="1999" name="J. Biol. Chem." volume="274" first="16871" last="16875">
<title>RIP3, a novel apoptosis-inducing kinase.</title>
<authorList>
<person name="Sun X."/>
<person name="Lee J."/>
<person name="Navas T."/>
<person name="Baldwin D.T."/>
<person name="Stewart T.A."/>
<person name="Dixit V.M."/>
</authorList>
<dbReference type="PubMed" id="10358032"/>
<dbReference type="DOI" id="10.1074/jbc.274.24.16871"/>
</citation>
<scope>INTERACTION WITH RIPK3</scope>
</reference>
<reference key="12">
<citation type="journal article" date="1999" name="Mol. Cell. Biol." volume="19" first="5759" last="5767">
<title>The Epstein-Barr virus oncoprotein latent membrane protein 1 engages the tumor necrosis factor receptor-associated proteins TRADD and receptor-interacting protein (RIP) but does not induce apoptosis or require RIP for NF-kappaB activation.</title>
<authorList>
<person name="Izumi K.M."/>
<person name="Cahir McFarland E."/>
<person name="Ting A.T."/>
<person name="Riley E.A."/>
<person name="Seed B."/>
<person name="Kieff E.D."/>
</authorList>
<dbReference type="PubMed" id="10409763"/>
<dbReference type="DOI" id="10.1128/MCB.19.8.5759"/>
</citation>
<scope>INTERACTION WITH BNLF1</scope>
</reference>
<reference key="13">
<citation type="journal article" date="1999" name="Proc. Natl. Acad. Sci. U.S.A." volume="96" first="1042" last="1047">
<title>Identification of a cell protein (FIP-3) as a modulator of NF-kappaB activity and as a target of an adenovirus inhibitor of tumor necrosis factor alpha-induced apoptosis.</title>
<authorList>
<person name="Li Y."/>
<person name="Kang J."/>
<person name="Friedman J."/>
<person name="Tarassishin L."/>
<person name="Ye J."/>
<person name="Kovalenko A."/>
<person name="Wallach D."/>
<person name="Horwitz M.S."/>
</authorList>
<dbReference type="PubMed" id="9927690"/>
<dbReference type="DOI" id="10.1073/pnas.96.3.1042"/>
</citation>
<scope>INTERACTION WITH IKBKG</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2000" name="Nat. Immunol." volume="1" first="489" last="495">
<title>Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule.</title>
<authorList>
<person name="Holler N."/>
<person name="Zaru R."/>
<person name="Micheau O."/>
<person name="Thome M."/>
<person name="Attinger A."/>
<person name="Valitutti S."/>
<person name="Bodmer J.L."/>
<person name="Schneider P."/>
<person name="Seed B."/>
<person name="Tschopp J."/>
</authorList>
<dbReference type="PubMed" id="11101870"/>
<dbReference type="DOI" id="10.1038/82732"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="8865" last="8874">
<title>The epidermal growth factor receptor engages receptor interacting protein and nuclear factor-kappa B (NF-kappa B)-inducing kinase to activate NF-kappa B. Identification of a novel receptor-tyrosine kinase signalosome.</title>
<authorList>
<person name="Habib A.A."/>
<person name="Chatterjee S."/>
<person name="Park S.-K."/>
<person name="Ratan R.R."/>
<person name="Lefebvre S."/>
<person name="Vartanian T."/>
</authorList>
<dbReference type="PubMed" id="11116146"/>
<dbReference type="DOI" id="10.1074/jbc.M008458200"/>
</citation>
<scope>INTERACTION WITH EGFR</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="15985" last="15991">
<title>A novel zinc finger protein interacts with receptor-interacting protein (RIP) and inhibits tumor necrosis factor (TNF)- and IL1-induced NF-kappa B activation.</title>
<authorList>
<person name="Chen D."/>
<person name="Li X."/>
<person name="Zhai Z."/>
<person name="Shu H.-B."/>
</authorList>
<dbReference type="PubMed" id="11854271"/>
<dbReference type="DOI" id="10.1074/jbc.M108675200"/>
</citation>
<scope>INTERACTION WITH RNF216</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="9505" last="9511">
<title>Identification of a novel homotypic interaction motif required for the phosphorylation of receptor-interacting protein (RIP) by RIP3.</title>
<authorList>
<person name="Sun X."/>
<person name="Yin J."/>
<person name="Starovasnik M.A."/>
<person name="Fairbrother W.J."/>
<person name="Dixit V.M."/>
</authorList>
<dbReference type="PubMed" id="11734559"/>
<dbReference type="DOI" id="10.1074/jbc.M109488200"/>
</citation>
<scope>RIP HOMOTYPIC INTERACTION MOTIF</scope>
<scope>INTERACTION WITH RIPK3</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2004" name="Anal. Chem." volume="76" first="2763" last="2772">
<title>Robust phosphoproteomic profiling of tyrosine phosphorylation sites from human T cells using immobilized metal affinity chromatography and tandem mass spectrometry.</title>
<authorList>
<person name="Brill L.M."/>
<person name="Salomon A.R."/>
<person name="Ficarro S.B."/>
<person name="Mukherji M."/>
<person name="Stettler-Gill M."/>
<person name="Peters E.C."/>
</authorList>
<dbReference type="PubMed" id="15144186"/>
<dbReference type="DOI" id="10.1021/ac035352d"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-384</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="19">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="16847" last="16853">
<title>ZNF216 is an A20-like and IkappaB kinase gamma-interacting inhibitor of NFkappaB activation.</title>
<authorList>
<person name="Huang J."/>
<person name="Teng L."/>
<person name="Li L."/>
<person name="Liu T."/>
<person name="Li L."/>
<person name="Chen D."/>
<person name="Xu L.-G."/>
<person name="Zhai Z."/>
<person name="Shu H.-B."/>
</authorList>
<dbReference type="PubMed" id="14754897"/>
<dbReference type="DOI" id="10.1074/jbc.M309491200"/>
</citation>
<scope>INTERACTION WITH ZFAND5</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2004" name="Nature" volume="430" first="694" last="699">
<title>De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling.</title>
<authorList>
<person name="Wertz I.E."/>
<person name="O'Rourke K.M."/>
<person name="Zhou H."/>
<person name="Eby M."/>
<person name="Aravind L."/>
<person name="Seshagiri S."/>
<person name="Wu P."/>
<person name="Wiesmann C."/>
<person name="Baker R."/>
<person name="Boone D.L."/>
<person name="Ma A."/>
<person name="Koonin E.V."/>
<person name="Dixit V.M."/>
</authorList>
<dbReference type="PubMed" id="15258597"/>
<dbReference type="DOI" id="10.1038/nature02794"/>
</citation>
<scope>UBIQUITINATION BY TRAF2</scope>
<scope>DEUBIQUITINATION BY TNFAIP3</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2005" name="Nat. Immunol." volume="6" first="981" last="988">
<title>IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction.</title>
<authorList>
<person name="Kawai T."/>
<person name="Takahashi K."/>
<person name="Sato S."/>
<person name="Coban C."/>
<person name="Kumar H."/>
<person name="Kato H."/>
<person name="Ishii K.J."/>
<person name="Takeuchi O."/>
<person name="Akira S."/>
</authorList>
<dbReference type="PubMed" id="16127453"/>
<dbReference type="DOI" id="10.1038/ni1243"/>
</citation>
<scope>INTERACTION WITH MAVS</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2006" name="Mol. Cell" volume="22" first="245" last="257">
<title>Activation of IKK by TNFalpha requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO.</title>
<authorList>
<person name="Ea C.K."/>
<person name="Deng L."/>
<person name="Xia Z.P."/>
<person name="Pineda G."/>
<person name="Chen Z.J."/>
</authorList>
<dbReference type="PubMed" id="16603398"/>
<dbReference type="DOI" id="10.1016/j.molcel.2006.03.026"/>
</citation>
<scope>UBIQUITINATION AT LYS-377</scope>
<scope>MUTAGENESIS OF LYS-377</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2007" name="Cell Death Differ." volume="14" first="400" last="410">
<title>RIP1, a kinase on the crossroads of a cell's decision to live or die.</title>
<authorList>
<person name="Festjens N."/>
<person name="Vanden Berghe T."/>
<person name="Cornelis S."/>
<person name="Vandenabeele P."/>
</authorList>
<dbReference type="PubMed" id="17301840"/>
<dbReference type="DOI" id="10.1038/sj.cdd.4402085"/>
</citation>
<scope>REVIEW</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2007" name="J. Biol. Chem." volume="282" first="14788" last="14796">
<title>RIP1-mediated AIP1 phosphorylation at a 14-3-3-binding site is critical for tumor necrosis factor-induced ASK1-JNK/p38 activation.</title>
<authorList>
<person name="Zhang H."/>
<person name="Zhang H."/>
<person name="Lin Y."/>
<person name="Li J."/>
<person name="Pober J.S."/>
<person name="Min W."/>
</authorList>
<dbReference type="PubMed" id="17389591"/>
<dbReference type="DOI" id="10.1074/jbc.M701148200"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF DAB2IP</scope>
<scope>INTERACTION WITH DAB2IP</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2007" name="J. Biol. Chem." volume="282" first="16776" last="16782">
<title>RBCK1 negatively regulates tumor necrosis factor- and interleukin-1-triggered NF-kappaB activation by targeting TAB2/3 for degradation.</title>
<authorList>
<person name="Tian Y."/>
<person name="Zhang Y."/>
<person name="Zhong B."/>
<person name="Wang Y.Y."/>
<person name="Diao F.C."/>
<person name="Wang R.P."/>
<person name="Zhang M."/>
<person name="Chen D.Y."/>
<person name="Zhai Z.H."/>
<person name="Shu H.B."/>
</authorList>
<dbReference type="PubMed" id="17449468"/>
<dbReference type="DOI" id="10.1074/jbc.M701913200"/>
</citation>
<scope>INTERACTION WITH RBCK1</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2008" name="Curr. Biol." volume="18" first="641" last="649">
<title>CARP-2 is an endosome-associated ubiquitin ligase for RIP and regulates TNF-induced NF-kappaB activation.</title>
<authorList>
<person name="Liao W."/>
<person name="Xiao Q."/>
<person name="Tchikov V."/>
<person name="Fujita K."/>
<person name="Yang W."/>
<person name="Wincovitch S."/>
<person name="Garfield S."/>
<person name="Conze D."/>
<person name="El-Deiry W.S."/>
<person name="Schuetze S."/>
<person name="Srinivasula S.M."/>
</authorList>
<dbReference type="PubMed" id="18450452"/>
<dbReference type="DOI" id="10.1016/j.cub.2008.04.017"/>
</citation>
<scope>INTERACTION WITH RFFL</scope>
<scope>UBIQUITINATION BY RFFL</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2008" name="Nat. Chem. Biol." volume="4" first="313" last="321">
<title>Identification of RIP1 kinase as a specific cellular target of necrostatins.</title>
<authorList>
<person name="Degterev A."/>
<person name="Hitomi J."/>
<person name="Germscheid M."/>
<person name="Ch'en I.L."/>
<person name="Korkina O."/>
<person name="Teng X."/>
<person name="Abbott D."/>
<person name="Cuny G.D."/>
<person name="Yuan C."/>
<person name="Wagner G."/>
<person name="Hedrick S.M."/>
<person name="Gerber S.A."/>
<person name="Lugovskoy A."/>
<person name="Yuan J."/>
</authorList>
<dbReference type="PubMed" id="18408713"/>
<dbReference type="DOI" id="10.1038/nchembio.83"/>
</citation>
<scope>MUTAGENESIS OF SER-161</scope>
<scope>INHIBITION BY NECROSTATIN-1</scope>
<scope>PHOSPHORYLATION AT SER-6; SER-20; SER-25; SER-161; SER-166; SER-303; SER-320 AND SER-333</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2008" name="J. Biol. Chem." volume="283" first="16966" last="16970">
<title>Cytomegalovirus M45 cell death suppression requires receptor-interacting protein (RIP) homotypic interaction motif (RHIM)-dependent interaction with RIP1.</title>
<authorList>
<person name="Upton J.W."/>
<person name="Kaiser W.J."/>
<person name="Mocarski E.S."/>
</authorList>
<dbReference type="PubMed" id="18442983"/>
<dbReference type="DOI" id="10.1074/jbc.C800051200"/>
</citation>
<scope>INTERACTION WITH MURID HERPESVIRUS 1 VIRAL INHIBITOR OF RIP ACTIVATION</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-320</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="30">
<citation type="journal article" date="2009" name="Cell" volume="137" first="1112" last="1123">
<title>Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation.</title>
<authorList>
<person name="Cho Y.S."/>
<person name="Challa S."/>
<person name="Moquin D."/>
<person name="Genga R."/>
<person name="Ray T.D."/>
<person name="Guildford M."/>
<person name="Chan F.K."/>
</authorList>
<dbReference type="PubMed" id="19524513"/>
<dbReference type="DOI" id="10.1016/j.cell.2009.05.037"/>
</citation>
<scope>FUNCTION</scope>
<scope>PHOSPHORYLATION</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2009" name="Cell" volume="137" first="1100" last="1111">
<title>Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha.</title>
<authorList>
<person name="He S."/>
<person name="Wang L."/>
<person name="Miao L."/>
<person name="Wang T."/>
<person name="Du F."/>
<person name="Zhao L."/>
<person name="Wang X."/>
</authorList>
<dbReference type="PubMed" id="19524512"/>
<dbReference type="DOI" id="10.1016/j.cell.2009.05.021"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH RIPK3</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2009" name="Curr. Biol." volume="19" first="R17" last="R19">
<title>Response: CARP1 regulates induction of NF-kappaB by TNFalpha.</title>
<authorList>
<person name="Liao W."/>
<person name="Fujita K."/>
<person name="Xiao Q."/>
<person name="Tchikov V."/>
<person name="Yang W."/>
<person name="Gunsor M."/>
<person name="Garfield S."/>
<person name="Goldsmith P."/>
<person name="El-Deiry W.S."/>
<person name="Schuetze S."/>
<person name="Srinivasula S.M."/>
</authorList>
<dbReference type="DOI" id="10.1016/j.cub.2008.11.041"/>
</citation>
<scope>INTERACTION WITH RNF34</scope>
<scope>UBIQUITINATION BY RNF34</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RE4" last="RE4">
<title>The role of the kinases RIP1 and RIP3 in TNF-induced necrosis.</title>
<authorList>
<person name="Vandenabeele P."/>
<person name="Declercq W."/>
<person name="Van Herreweghe F."/>
<person name="Vanden Berghe T."/>
</authorList>
<dbReference type="PubMed" id="20354226"/>
<dbReference type="DOI" id="10.1126/scisignal.3115re4"/>
</citation>
<scope>REVIEW</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2011" name="Nature" volume="471" first="591" last="596">
<title>Linear ubiquitination prevents inflammation and regulates immune signalling.</title>
<authorList>
<person name="Gerlach B."/>
<person name="Cordier S.M."/>
<person name="Schmukle A.C."/>
<person name="Emmerich C.H."/>
<person name="Rieser E."/>
<person name="Haas T.L."/>
<person name="Webb A.I."/>
<person name="Rickard J.A."/>
<person name="Anderton H."/>
<person name="Wong W.W."/>
<person name="Nachbur U."/>
<person name="Gangoda L."/>
<person name="Warnken U."/>
<person name="Purcell A.W."/>
<person name="Silke J."/>
<person name="Walczak H."/>
</authorList>
<dbReference type="PubMed" id="21455173"/>
<dbReference type="DOI" id="10.1038/nature09816"/>
</citation>
<scope>UBIQUITINATION BY THE LUBAC COMPLEX</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2011" name="PLoS ONE" volume="6" first="E22356" last="E22356">
<title>cIAP1/2 are direct E3 ligases conjugating diverse types of ubiquitin chains to receptor interacting proteins kinases 1 to 4 (RIP1-4).</title>
<authorList>
<person name="Bertrand M.J."/>
<person name="Lippens S."/>
<person name="Staes A."/>
<person name="Gilbert B."/>
<person name="Roelandt R."/>
<person name="De Medts J."/>
<person name="Gevaert K."/>
<person name="Declercq W."/>
<person name="Vandenabeele P."/>
</authorList>
<dbReference type="PubMed" id="21931591"/>
<dbReference type="DOI" id="10.1371/journal.pone.0022356"/>
</citation>
<scope>UBIQUITINATION BY BIRC2/C-IAP1 AND BIRC3/C-IAP2</scope>
<scope>INTERACTION WITH BIRC2/C-IAP1; BIRC3/C-IAP2 AND XIAP/BIRC4</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2012" name="Cell" volume="148" first="228" last="243">
<title>The mitochondrial phosphatase PGAM5 functions at the convergence point of multiple necrotic death pathways.</title>
<authorList>
<person name="Wang Z."/>
<person name="Jiang H."/>
<person name="Chen S."/>
<person name="Du F."/>
<person name="Wang X."/>
</authorList>
<dbReference type="PubMed" id="22265414"/>
<dbReference type="DOI" id="10.1016/j.cell.2011.11.030"/>
</citation>
<scope>IDENTIFICATION IN COMPLEX WITH PGAM5; RIPK3 AND MLKL</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2012" name="Inflamm. Bowel Dis." volume="18" first="603" last="612">
<title>Control of NOD2 and Rip2-dependent innate immune activation by GEF-H1.</title>
<authorList>
<person name="Zhao Y."/>
<person name="Alonso C."/>
<person name="Ballester I."/>
<person name="Song J.H."/>
<person name="Chang S.Y."/>
<person name="Guleng B."/>
<person name="Arihiro S."/>
<person name="Murray P.J."/>
<person name="Xavier R."/>
<person name="Kobayashi K.S."/>
<person name="Reinecker H.C."/>
</authorList>
<dbReference type="PubMed" id="21887730"/>
<dbReference type="DOI" id="10.1002/ibd.21851"/>
</citation>
<scope>INTERACTION WITH ARHGEF2</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-320</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="40">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="41">
<citation type="journal article" date="2015" name="EMBO Rep." volume="16" first="447" last="455">
<title>WDFY1 mediates TLR3/4 signaling by recruiting TRIF.</title>
<authorList>
<person name="Hu Y.H."/>
<person name="Zhang Y."/>
<person name="Jiang L.Q."/>
<person name="Wang S."/>
<person name="Lei C.Q."/>
<person name="Sun M.S."/>
<person name="Shu H.B."/>
<person name="Liu Y."/>
</authorList>
<dbReference type="PubMed" id="25736436"/>
<dbReference type="DOI" id="10.15252/embr.201439637"/>
</citation>
<scope>INTERACTION WITH TICAM1</scope>
</reference>
<reference key="42">
<citation type="journal article" date="2013" name="Structure" volume="21" first="493" last="499">
<title>Structural basis of RIP1 inhibition by necrostatins.</title>
<authorList>
<person name="Xie T."/>
<person name="Peng W."/>
<person name="Liu Y."/>
<person name="Yan C."/>
<person name="Maki J."/>
<person name="Degterev A."/>
<person name="Yuan J."/>
<person name="Shi Y."/>
</authorList>
<dbReference type="PubMed" id="23473668"/>
<dbReference type="DOI" id="10.1016/j.str.2013.01.016"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 1-294 IN COMPLEXES WITH NECROSTATIN-TYPE INHIBITORS</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>ENZYME REGULATION</scope>
<scope>AUTOPHOSPHORYLATION</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2007" name="Nature" volume="446" first="153" last="158">
<title>Patterns of somatic mutation in human cancer genomes.</title>
<authorList>
<person name="Greenman C."/>
<person name="Stephens P."/>
<person name="Smith R."/>
<person name="Dalgliesh G.L."/>
<person name="Hunter C."/>
<person name="Bignell G."/>
<person name="Davies H."/>
<person name="Teague J."/>
<person name="Butler A."/>
<person name="Stevens C."/>
<person name="Edkins S."/>
<person name="O'Meara S."/>
<person name="Vastrik I."/>
<person name="Schmidt E.E."/>
<person name="Avis T."/>
<person name="Barthorpe S."/>
<person name="Bhamra G."/>
<person name="Buck G."/>
<person name="Choudhury B."/>
<person name="Clements J."/>
<person name="Cole J."/>
<person name="Dicks E."/>
<person name="Forbes S."/>
<person name="Gray K."/>
<person name="Halliday K."/>
<person name="Harrison R."/>
<person name="Hills K."/>
<person name="Hinton J."/>
<person name="Jenkinson A."/>
<person name="Jones D."/>
<person name="Menzies A."/>
<person name="Mironenko T."/>
<person name="Perry J."/>
<person name="Raine K."/>
<person name="Richardson D."/>
<person name="Shepherd R."/>
<person name="Small A."/>
<person name="Tofts C."/>
<person name="Varian J."/>
<person name="Webb T."/>
<person name="West S."/>
<person name="Widaa S."/>
<person name="Yates A."/>
<person name="Cahill D.P."/>
<person name="Louis D.N."/>
<person name="Goldstraw P."/>
<person name="Nicholson A.G."/>
<person name="Brasseur F."/>
<person name="Looijenga L."/>
<person name="Weber B.L."/>
<person name="Chiew Y.-E."/>
<person name="DeFazio A."/>
<person name="Greaves M.F."/>
<person name="Green A.R."/>
<person name="Campbell P."/>
<person name="Birney E."/>
<person name="Easton D.F."/>
<person name="Chenevix-Trench G."/>
<person name="Tan M.-H."/>
<person name="Khoo S.K."/>
<person name="Teh B.T."/>
<person name="Yuen S.T."/>
<person name="Leung S.Y."/>
<person name="Wooster R."/>
<person name="Futreal P.A."/>
<person name="Stratton M.R."/>
</authorList>
<dbReference type="PubMed" id="17344846"/>
<dbReference type="DOI" id="10.1038/nature05610"/>
</citation>
<scope>VARIANTS [LARGE SCALE ANALYSIS] VAL-64; ILE-81; VAL-220; SER-404; VAL-443 AND VAL-569</scope>
</reference>
<comment type="function">
<text evidence="19 29 34 35">Serine-threonine kinase which transduces inflammatory and cell-death signals (programmed necrosis) following death receptors ligation, activation of pathogen recognition receptors (PRRs), and DNA damage. Upon activation of TNFR1 by the TNF-alpha family cytokines, TRADD and TRAF2 are recruited to the receptor. Phosphorylates DAB2IP at 'Ser-728' in a TNF-alpha-dependent manner, and thereby activates the MAP3K5-JNK apoptotic cascade. Ubiquitination by TRAF2 via 'Lys-63'-link chains acts as a critical enhancer of communication with downstream signal transducers in the mitogen-activated protein kinase pathway and the NF-kappa-B pathway, which in turn mediate downstream events including the activation of genes encoding inflammatory molecules. Polyubiquitinated protein binds to IKBKG/NEMO, the regulatory subunit of the IKK complex, a critical event for NF-kappa-B activation. Interaction with other cellular RHIM-containing adapters initiates gene activation and cell death. RIPK1 and RIPK3 association, in particular, forms a necrosis-inducing complex.</text>
</comment>
<comment type="catalytic activity">
<text evidence="40">ATP + a protein = ADP + a phosphoprotein.</text>
</comment>
<comment type="enzyme regulation">
<text evidence="40">Inhibited by necrostatins, including necrostatin-1, necrostatin-3 and necrostatin-4.</text>
</comment>
<comment type="subunit">
<text evidence="10 15 16 17 20 21 22 23 26 29 30 32 33 34 37 38 39 41 43 44 45">Interacts (via RIP homotypic interaction motif) with RIPK3 (via RIP homotypic interaction motif). Upon TNF-induced necrosis, the RIPK1-RIPK3 dimer further interacts with PGAM5 and MLKL; the formation of this complex leads to PGAM5 phosphorylation and increase in PGAM5 phosphatase activity. Interacts (via the death domain) with TNFRSF6 (via the death domain) and TRADD (via the death domain). Is recruited by TRADD to TNFRSF1A in a TNF-dependent process. Binds RNF216, EGFR, IKBKG, TRAF1, TRAF2 and TRAF3. Interacts with BNLF1. Interacts with SQSTM1 upon TNF-alpha stimulation. May interact with MAVS/IPS1. Interacts with ZFAND5. Interacts with RBCK1 (By similarity). Interacts with ZBP1 (By similarity). Interacts with BIRC2/c-IAP1, BIRC3/c-IAP2 and XIAP/BIRC4. Upon TNF-induced necrosis, forms in complex with PGAM5, RIPK3 and MLKL. Interacts (via kinase domain) with DAB2IP (via Ras-GAP domain); the interaction occurs in a TNF-alpha-dependent manner. Interacts with ARHGEF2. Interacts (via protein kinase domain) with RFFL; involved in RIPK1 ubiquitination. Interacts with RNF34; involved in RIPK1 ubiquitination. Interacts with TICAM1 and this interaction is enhanced in the presence of WDFY1 (PubMed:25736436).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-358507"/>
<interactant intactId="EBI-358507"/>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-358507"/>
<interactant intactId="EBI-354007">
<id>P04083</id>
<label>ANXA1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-358507"/>
<interactant intactId="EBI-514538">
<id>Q13490</id>
<label>BIRC2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-358507"/>
<interactant intactId="EBI-517709">
<id>Q13489</id>
<label>BIRC3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-358507"/>
<interactant intactId="EBI-495095">
<id>Q92851</id>
<label>CASP10</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-358507"/>
<interactant intactId="EBI-78060">
<id>Q14790</id>
<label>CASP8</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>24</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-358507"/>
<interactant intactId="EBI-723996">
<id>Q8IVM0</id>
<label>CCDC50</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-358507"/>
<interactant intactId="EBI-1383726">
<id>P48729</id>
<label>CSNK1A1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-358507"/>
<interactant intactId="EBI-494804">
<id>Q13158</id>
<label>FADD</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>9</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-358507"/>
<interactant intactId="EBI-81279">
<id>Q9Y6K9</id>
<label>IKBKG</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-358507"/>
<interactant intactId="EBI-751215">
<id>Q9ULZ3</id>
<label>PYCARD</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-358507"/>
<interactant intactId="EBI-298250">
<id>Q9Y572</id>
<label>RIPK3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>26</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-358507"/>
<interactant intactId="EBI-2367423">
<id>Q9QZL0</id>
<label>Ripk3</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-358507"/>
<interactant intactId="EBI-299451">
<id>P19438</id>
<label>TNFRSF1A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-358507"/>
<interactant intactId="EBI-359224">
<id>Q13077</id>
<label>TRAF1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-358507"/>
<interactant intactId="EBI-355744">
<id>Q12933</id>
<label>TRAF2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-358507"/>
<interactant intactId="EBI-11894787">
<id>U5TQE9</id>
<label>UL39</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-358507"/>
<interactant intactId="EBI-723290">
<id>Q13107</id>
<label>USP4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="9">Cell membrane</location>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q13546-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q13546-2</id>
<name>2</name>
<sequence type="described" ref="VSP_037690"/>
<text>No experimental confirmation available.</text>
</isoform>
</comment>
<comment type="domain">
<text evidence="15">Contains a C-terminal death domain (DD) that engages other DD-containing proteins as well as a central (intermediate) region important for NF-kB activation and RHIM-dependent signaling.</text>
</comment>
<comment type="PTM">
<text evidence="18">Proteolytically cleaved by caspase-8 during TNF-induced apoptosis. Cleavage abolishes NF-kappa-B activation and enhances pro-apoptotic signaling through the TRADD-FADD interaction.</text>
</comment>
<comment type="PTM">
<text evidence="31 35">RIPK1 and RIPK3 undergo reciprocal auto- and trans-phosphorylation. Phosphorylation of Ser-161 by RIPK3 is necessary for the formation of the necroptosis-inducing complex.</text>
</comment>
<comment type="PTM">
<text evidence="24 27 33 36 38 45">Ubiquitinated by 'Lys-11'-, 'Lys-48'-, 'Lys-63'- and linear-linked type ubiquitin. Polyubiquitination with 'Lys-63'-linked chains by TRAF2 induces association with the IKK complex. Deubiquitination of 'Lys-63'-linked chains and polyubiquitination with 'Lys-48'-linked chains by TNFAIP3 leads to RIPK1 proteasomal degradation and consequently down-regulates TNF-alpha-induced NFkappa-B signaling. 'Lys-48'-linked polyubiquitination by RFFL or RNF34 also promotes proteasomal degradation and negatively regulates TNF-alpha-induced NFkappa-B signaling. Linear polyubiquitinated; the head-to-tail polyubiquitination is mediated by the LUBAC complex. LPS-mediated activation of NF-kappa-B. Also ubiquitinated with 'Lys-11'-linked chains. Polyubiquitinated with 'Lys-48' and 'Lys-63'-linked chains by BIRC2/c-IAP1 and BIRC3/c-IAP2, leading to activation of NF-kappa-B.</text>
</comment>
<comment type="similarity">
<text evidence="48">Belongs to the protein kinase superfamily. TKL Ser/Thr protein kinase family.</text>
</comment>
<comment type="sequence caution" evidence="48">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="BAG65471" version="1"/>
</conflict>
</comment>
<comment type="online information" name="SeattleSNPs">
<link uri="http://pga.gs.washington.edu/data/ripk1/"/>
</comment>
<dbReference type="EC" id="2.7.11.1"/>
<dbReference type="EMBL" id="U50062">
<property type="protein sequence ID" value="AAC32232.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK314176">
<property type="protein sequence ID" value="BAG36858.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK304701">
<property type="protein sequence ID" value="BAG65471.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY682848">
<property type="protein sequence ID" value="AAT74626.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL031963">
<property type="protein sequence ID" value="CAD70625.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC126254">
<property type="protein sequence ID" value="AAI26255.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC126256">
<property type="protein sequence ID" value="AAI26257.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB208926">
<property type="protein sequence ID" value="BAD92163.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U25994">
<property type="protein sequence ID" value="AAC50137.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS4482.1">
<molecule id="Q13546-1"/>
</dbReference>
<dbReference type="PIR" id="T09479">
<property type="entry name" value="T09479"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001303990.1">
<property type="nucleotide sequence ID" value="NM_001317061.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_003795.2">
<molecule id="Q13546-1"/>
<property type="nucleotide sequence ID" value="NM_003804.4"/>
</dbReference>
<dbReference type="RefSeq" id="XP_005249514.2">
<molecule id="Q13546-1"/>
<property type="nucleotide sequence ID" value="XM_005249457.3"/>
</dbReference>
<dbReference type="UniGene" id="Hs.519842"/>
<dbReference type="PDB" id="4ITH">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.25"/>
<property type="chains" value="A/B=1-294"/>
</dbReference>
<dbReference type="PDB" id="4ITI">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.86"/>
<property type="chains" value="A/B=1-294"/>
</dbReference>
<dbReference type="PDB" id="4ITJ">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A/B=1-294"/>
</dbReference>
<dbReference type="PDB" id="4NEU">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.57"/>
<property type="chains" value="A/B=1-324"/>
</dbReference>
<dbReference type="PDB" id="5HX6">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.23"/>
<property type="chains" value="A/B=1-294"/>
</dbReference>
<dbReference type="PDBsum" id="4ITH"/>
<dbReference type="PDBsum" id="4ITI"/>
<dbReference type="PDBsum" id="4ITJ"/>
<dbReference type="PDBsum" id="4NEU"/>
<dbReference type="PDBsum" id="5HX6"/>
<dbReference type="ProteinModelPortal" id="Q13546"/>
<dbReference type="SMR" id="Q13546"/>
<dbReference type="BioGrid" id="114274">
<property type="interactions" value="79"/>
</dbReference>
<dbReference type="DIP" id="DIP-433N"/>
<dbReference type="IntAct" id="Q13546">
<property type="interactions" value="38"/>
</dbReference>
<dbReference type="MINT" id="MINT-128219"/>
<dbReference type="STRING" id="9606.ENSP00000259808"/>
<dbReference type="BindingDB" id="Q13546"/>
<dbReference type="ChEMBL" id="CHEMBL5464"/>
<dbReference type="GuidetoPHARMACOLOGY" id="2189"/>
<dbReference type="iPTMnet" id="Q13546"/>
<dbReference type="PhosphoSitePlus" id="Q13546"/>
<dbReference type="BioMuta" id="RIPK1"/>
<dbReference type="DMDM" id="60393639"/>
<dbReference type="EPD" id="Q13546"/>
<dbReference type="MaxQB" id="Q13546"/>
<dbReference type="PaxDb" id="Q13546"/>
<dbReference type="PeptideAtlas" id="Q13546"/>
<dbReference type="PRIDE" id="Q13546"/>
<dbReference type="DNASU" id="8737"/>
<dbReference type="Ensembl" id="ENST00000259808">
<molecule id="Q13546-1"/>
<property type="protein sequence ID" value="ENSP00000259808"/>
<property type="gene ID" value="ENSG00000137275"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000380409">
<molecule id="Q13546-1"/>
<property type="protein sequence ID" value="ENSP00000369773"/>
<property type="gene ID" value="ENSG00000137275"/>
</dbReference>
<dbReference type="GeneID" id="8737"/>
<dbReference type="KEGG" id="hsa:8737"/>
<dbReference type="UCSC" id="uc003mux.4">
<molecule id="Q13546-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="8737"/>
<dbReference type="DisGeNET" id="8737"/>
<dbReference type="GeneCards" id="RIPK1"/>
<dbReference type="HGNC" id="HGNC:10019">
<property type="gene designation" value="RIPK1"/>
</dbReference>
<dbReference type="HPA" id="CAB010302"/>
<dbReference type="HPA" id="HPA015257"/>
<dbReference type="MIM" id="603453">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q13546"/>
<dbReference type="OpenTargets" id="ENSG00000137275"/>
<dbReference type="PharmGKB" id="PA34394"/>
<dbReference type="eggNOG" id="KOG0192">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="COG0515">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00550000074536"/>
<dbReference type="HOGENOM" id="HOG000010270"/>
<dbReference type="HOVERGEN" id="HBG055612"/>
<dbReference type="InParanoid" id="Q13546"/>
<dbReference type="KO" id="K02861"/>
<dbReference type="OMA" id="VVKRMQS"/>
<dbReference type="OrthoDB" id="EOG091G0479"/>
<dbReference type="PhylomeDB" id="Q13546"/>
<dbReference type="TreeFam" id="TF106506"/>
<dbReference type="BRENDA" id="2.7.10.2">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-140534">
<property type="pathway name" value="Ligand-dependent caspase activation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1810476">
<property type="pathway name" value="RIP-mediated NFkB activation via ZBP1"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2562578">
<property type="pathway name" value="TRIF-mediated programmed cell death"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-3295583">
<property type="pathway name" value="TRP channels"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-3371378">
<property type="pathway name" value="Regulation by c-FLIP"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5213460">
<property type="pathway name" value="RIPK1-mediated regulated necrosis"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5218900">
<property type="pathway name" value="CASP8 activity is inhibited"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5357786">
<property type="pathway name" value="TNFR1-induced proapoptotic signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5357905">
<property type="pathway name" value="Regulation of TNFR1 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5357956">
<property type="pathway name" value="TNFR1-induced NFkappaB signaling pathway"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5675482">
<property type="pathway name" value="Regulation of necroptotic cell death"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5689880">
<property type="pathway name" value="Ub-specific processing proteases"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5689896">
<property type="pathway name" value="Ovarian tumor domain proteases"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-69416">
<property type="pathway name" value="Dimerization of procaspase-8"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-75893">
<property type="pathway name" value="TNF signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-933543">
<property type="pathway name" value="NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-937041">
<property type="pathway name" value="IKK complex recruitment mediated by RIP1"/>
</dbReference>
<dbReference type="SignaLink" id="Q13546"/>
<dbReference type="SIGNOR" id="Q13546"/>
<dbReference type="ChiTaRS" id="RIPK1">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GeneWiki" id="RIPK1"/>
<dbReference type="GenomeRNAi" id="8737"/>
<dbReference type="PMAP-CutDB" id="Q13546"/>
<dbReference type="PRO" id="PR:Q13546"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 6"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000137275"/>
<dbReference type="CleanEx" id="HS_RIPK1"/>
<dbReference type="ExpressionAtlas" id="Q13546">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q13546">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0031264">
<property type="term" value="C:death-inducing signaling complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045121">
<property type="term" value="C:membrane raft"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005739">
<property type="term" value="C:mitochondrion"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043235">
<property type="term" value="C:receptor complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0097342">
<property type="term" value="C:ripoptosome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0070513">
<property type="term" value="F:death domain binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005123">
<property type="term" value="F:death receptor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042802">
<property type="term" value="F:identical protein binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="IntAct"/>
</dbReference>
<dbReference type="GO" id="GO:0032403">
<property type="term" value="F:protein complex binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004672">
<property type="term" value="F:protein kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004674">
<property type="term" value="F:protein serine/threonine kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004871">
<property type="term" value="F:signal transducer activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0031625">
<property type="term" value="F:ubiquitin protein ligase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006919">
<property type="term" value="P:activation of cysteine-type endopeptidase activity involved in apoptotic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0097296">
<property type="term" value="P:activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0007257">
<property type="term" value="P:activation of JUN kinase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1990000">
<property type="term" value="P:amyloid fibril formation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006915">
<property type="term" value="P:apoptotic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0097190">
<property type="term" value="P:apoptotic signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0044257">
<property type="term" value="P:cellular protein catabolic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071363">
<property type="term" value="P:cellular response to growth factor stimulus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0071356">
<property type="term" value="P:cellular response to tumor necrosis factor"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071550">
<property type="term" value="P:death-inducing signaling complex assembly"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0097191">
<property type="term" value="P:extrinsic apoptotic signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0007249">
<property type="term" value="P:I-kappaB kinase/NF-kappaB signaling"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0070266">
<property type="term" value="P:necroptotic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0097527">
<property type="term" value="P:necroptotic signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:2001237">
<property type="term" value="P:negative regulation of extrinsic apoptotic signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2001240">
<property type="term" value="P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:1902042">
<property type="term" value="P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0043124">
<property type="term" value="P:negative regulation of I-kappaB kinase/NF-kappaB signaling"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0036289">
<property type="term" value="P:peptidyl-serine autophosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043065">
<property type="term" value="P:positive regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2001238">
<property type="term" value="P:positive regulation of extrinsic apoptotic signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1905206">
<property type="term" value="P:positive regulation of hydrogen peroxide-induced cell death"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043123">
<property type="term" value="P:positive regulation of I-kappaB kinase/NF-kappaB signaling"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032757">
<property type="term" value="P:positive regulation of interleukin-8 production"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0046330">
<property type="term" value="P:positive regulation of JNK cascade"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045651">
<property type="term" value="P:positive regulation of macrophage differentiation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0060545">
<property type="term" value="P:positive regulation of necroptotic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010940">
<property type="term" value="P:positive regulation of necrotic cell death"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0051092">
<property type="term" value="P:positive regulation of NF-kappaB transcription factor activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043068">
<property type="term" value="P:positive regulation of programmed cell death"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001934">
<property type="term" value="P:positive regulation of protein phosphorylation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2000379">
<property type="term" value="P:positive regulation of reactive oxygen species metabolic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045944">
<property type="term" value="P:positive regulation of transcription from RNA polymerase II promoter"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032760">
<property type="term" value="P:positive regulation of tumor necrosis factor production"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0046777">
<property type="term" value="P:protein autophosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0016579">
<property type="term" value="P:protein deubiquitination"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0051291">
<property type="term" value="P:protein heterooligomerization"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051260">
<property type="term" value="P:protein homooligomerization"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070926">
<property type="term" value="P:regulation of ATP:ADP antiporter activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1902041">
<property type="term" value="P:regulation of extrinsic apoptotic signaling pathway via death domain receptors"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0060544">
<property type="term" value="P:regulation of necroptotic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0010803">
<property type="term" value="P:regulation of tumor necrosis factor-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0034612">
<property type="term" value="P:response to tumor necrosis factor"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0097343">
<property type="term" value="P:ripoptosome assembly"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1901026">
<property type="term" value="P:ripoptosome assembly involved in necroptotic process"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0070231">
<property type="term" value="P:T cell apoptotic process"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035666">
<property type="term" value="P:TRIF-dependent toll-like receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0033209">
<property type="term" value="P:tumor necrosis factor-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="InterPro" id="IPR011029">
<property type="entry name" value="DEATH-like_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR000488">
<property type="entry name" value="Death_domain"/>
</dbReference>
<dbReference type="InterPro" id="IPR011009">
<property type="entry name" value="Kinase-like_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR000719">
<property type="entry name" value="Prot_kinase_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR025735">
<property type="entry name" value="RHIM_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR001245">
<property type="entry name" value="Ser-Thr/Tyr_kinase_cat_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR008271">
<property type="entry name" value="Ser/Thr_kinase_AS"/>
</dbReference>
<dbReference type="Pfam" id="PF00531">
<property type="entry name" value="Death"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF07714">
<property type="entry name" value="Pkinase_Tyr"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF12721">
<property type="entry name" value="RHIM"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00109">
<property type="entry name" value="TYRKINASE"/>
</dbReference>
<dbReference type="SMART" id="SM00005">
<property type="entry name" value="DEATH"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00220">
<property type="entry name" value="S_TKc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF47986">
<property type="entry name" value="SSF47986"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF56112">
<property type="entry name" value="SSF56112"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50017">
<property type="entry name" value="DEATH_DOMAIN"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50011">
<property type="entry name" value="PROTEIN_KINASE_DOM"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00108">
<property type="entry name" value="PROTEIN_KINASE_ST"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0418">Kinase</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-1210">Necrosis</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0723">Serine/threonine-protein kinase</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="chain" description="Receptor-interacting serine/threonine-protein kinase 1" id="PRO_0000086606">
<location>
<begin position="1"/>
<end position="671"/>
</location>
</feature>
<feature type="domain" description="Protein kinase" evidence="13">
<location>
<begin position="17"/>
<end position="289"/>
</location>
</feature>
<feature type="domain" description="Death" evidence="12">
<location>
<begin position="583"/>
<end position="669"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="13">
<location>
<begin position="23"/>
<end position="31"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with SQSTM1" evidence="15">
<location>
<begin position="290"/>
<end position="582"/>
</location>
</feature>
<feature type="short sequence motif" description="RIP homotypic interaction motif (RHIM)">
<location>
<begin position="531"/>
<end position="547"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Arg">
<location>
<begin position="411"/>
<end position="414"/>
</location>
</feature>
<feature type="active site" description="Proton acceptor" evidence="13 14">
<location>
<position position="138"/>
</location>
</feature>
<feature type="binding site" description="ATP" evidence="13">
<location>
<position position="49"/>
</location>
</feature>
<feature type="site" description="Cleavage; by caspase-8">
<location>
<begin position="324"/>
<end position="325"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="31">
<location>
<position position="6"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by autocatalysis" evidence="11">
<location>
<position position="20"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="31">
<location>
<position position="25"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by RIPK3 and autocatalysis" evidence="11">
<location>
<position position="161"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by autocatalysis" evidence="11">
<location>
<position position="166"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="31">
<location>
<position position="303"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="7 8 31">
<location>
<position position="320"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="31">
<location>
<position position="333"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="6">
<location>
<position position="384"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_037690" evidence="47">
<location>
<begin position="108"/>
<end position="153"/>
</location>
</feature>
<feature type="sequence variant" description="In a colorectal adenocarcinoma sample; somatic mutation; dbSNP:rs774996232." id="VAR_041039" evidence="28">
<original>A</original>
<variation>V</variation>
<location>
<position position="64"/>
</location>
</feature>
<feature type="sequence variant" description="In a colorectal adenocarcinoma sample; somatic mutation; dbSNP:rs758268804." id="VAR_041040" evidence="28">
<original>V</original>
<variation>I</variation>
<location>
<position position="81"/>
</location>
</feature>
<feature type="sequence variant" description="In a colorectal adenocarcinoma sample; somatic mutation; dbSNP:rs759012409." id="VAR_041041" evidence="28">
<original>A</original>
<variation>V</variation>
<location>
<position position="220"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs17548383." id="VAR_021109" evidence="46">
<original>E</original>
<variation>K</variation>
<location>
<position position="234"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs34872409." id="VAR_041042" evidence="28">
<original>A</original>
<variation>S</variation>
<location>
<position position="404"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs3173519." id="VAR_058285" evidence="25 42 43">
<original>A</original>
<variation>V</variation>
<location>
<position position="438"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs35722193." id="VAR_041043" evidence="28">
<original>A</original>
<variation>V</variation>
<location>
<position position="443"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs55861377." id="VAR_041044" evidence="28">
<original>A</original>
<variation>V</variation>
<location>
<position position="569"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes kinase activity." evidence="43">
<original>K</original>
<variation>A</variation>
<location>
<position position="45"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreases RIPK1 kinase activity." evidence="31">
<original>S</original>
<variation>A</variation>
<location>
<position position="161"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on RIPK1 autophosphorylation." evidence="31">
<original>S</original>
<variation>E</variation>
<location>
<position position="161"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes cleavage by caspase-8." evidence="18">
<original>D</original>
<variation>K</variation>
<location>
<position position="324"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes RIP-mediated NF-Kappa-B activation." evidence="27">
<original>K</original>
<variation>R</variation>
<location>
<position position="377"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; BAG36858." ref="3" evidence="48">
<original>R</original>
<variation>I</variation>
<location>
<position position="258"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; BAG36858." ref="3" evidence="48">
<original>R</original>
<variation>S</variation>
<location>
<position position="286"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 8; AAC50137." ref="8" evidence="48">
<original>T</original>
<variation>S</variation>
<location>
<position position="514"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="14"/>
<end position="16"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="17"/>
<end position="19"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="20"/>
<end position="22"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="26"/>
<end position="28"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="30"/>
<end position="36"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="37"/>
<end position="39"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="40"/>
<end position="51"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="54"/>
<end position="56"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="57"/>
<end position="68"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="78"/>
<end position="84"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="87"/>
<end position="93"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="100"/>
<end position="104"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="106"/>
<end position="108"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="112"/>
<end position="131"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="141"/>
<end position="143"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="144"/>
<end position="146"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="152"/>
<end position="154"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="163"/>
<end position="168"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="171"/>
<end position="173"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="190"/>
<end position="192"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="195"/>
<end position="197"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="201"/>
<end position="203"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="207"/>
<end position="223"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="234"/>
<end position="242"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="249"/>
<end position="251"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="258"/>
<end position="267"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="272"/>
<end position="274"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="278"/>
<end position="292"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="294"/>
<end position="296"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="297"/>
<end position="309"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="310"/>
<end position="312"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4ITH"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4ITI"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4ITJ"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4NEU"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5HX6"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="15144186"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000250"/>
<evidence key="10" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q60855"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000255"/>
<evidence key="12" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00064"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00159"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU10027"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10356400"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10358032"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10409763"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10521396"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11101870"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11116146"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11734559"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11854271"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14754897"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15258597"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16127453"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16603398"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17344846"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17389591"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17449468"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18408713"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18442983"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18450452"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19524512"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19524513"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21455173"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21887730"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21931591"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22265414"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23473668"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25736436"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7538908"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8612133"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9927690"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000269">
<source ref="32"/>
</evidence>
<evidence key="46" type="ECO:0000269">
<source ref="4"/>
</evidence>
<evidence key="47" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000305"/>
<sequence length="671" mass="75931" checksum="976E2428D525A9B2" modified="2005-02-01" version="3">
MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEAL
LEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIIL
EIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVD
GTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMC
IKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEED
VKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFA
PSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPF
AQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLD
PGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQ
IGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKN
CARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRID
LLSSLIYVSQN
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>